These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2917195)

  • 1. Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood.
    Clozel M; Kuhn H; Baumgartner HR
    Blood; 1989 Feb; 73(3):729-33. PubMed ID: 2917195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.
    Zwaginga JJ; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(1):49-61. PubMed ID: 2297347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-thrombin bound to extracellular endothelial matrix induces pronounced fibrin deposition and platelet thrombus growth in flowing non-anticoagulated human blood.
    Salatti JA; Fenton J; Anton P; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):561-6. PubMed ID: 7841312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface.
    Diquélou A; Lemozy S; Dupouy D; Boneu B; Sakariassen K; Cadroy Y
    Blood; 1994 Oct; 84(7):2206-13. PubMed ID: 7919337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.
    Tijburg PN; Ryan J; Stern DM; Wollitzky B; Rimon S; Rimon A; Handley D; Nawroth P; Sixma JJ; de Groot PG
    J Biol Chem; 1991 Jun; 266(18):12067-74. PubMed ID: 2050700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions.
    Kirchhofer D; Sakariassen KS; Clozel M; Tschopp TB; Hadváry P; Nemerson Y; Baumgartner HR
    Blood; 1993 Apr; 81(8):2050-8. PubMed ID: 8097120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix.
    Lindahl AK; Sandset PM; Thune-Wiiger M; Nordfang O; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):755-60. PubMed ID: 7865681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
    Kirchhofer D; Tschopp TB; Steiner B; Baumgartner HR
    Blood; 1995 Nov; 86(10):3815-22. PubMed ID: 7579349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
    Kirchhofer D; Tschopp TB; Baumgartner HR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1098-106. PubMed ID: 7627702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
    Barstad RM; Buchmann MS; Hamers MJ; Orning L; Orvim U; Stormorken H; Sakariassen KS
    Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin.
    Sakariassen KS; Joss R; Muggli R; Kuhn H; Tschopp TB; Sage H; Baumgartner HR
    Arteriosclerosis; 1990; 10(2):276-84. PubMed ID: 2317161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts.
    Zwaginga JJ; de Boer HC; IJsseldijk MJ; Kerkhof A; Muller-Berghaus G; Gruhlichhenn J; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(3):437-48. PubMed ID: 2344300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.
    Sakariassen KS; Aarts PA; de Groot PG; Houdijk WP; Sixma JJ
    J Lab Clin Med; 1983 Oct; 102(4):522-35. PubMed ID: 6619647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.
    Badimon L; Badimon JJ; Turitto VT; Vallabhajosula S; Fuster V
    Circulation; 1988 Dec; 78(6):1431-42. PubMed ID: 3263902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms.
    Goel MS; Diamond SL
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2093-8. PubMed ID: 11742890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen. High shear rates induce decreased fibrin deposition and appearance of fibrin monomers.
    Tijburg PN; Ijsseldijk MJ; Sixma JJ; de Groot PG
    Arterioscler Thromb; 1991; 11(2):211-20. PubMed ID: 1998640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood.
    Badimon L; Badimon JJ; Rand J; Turitto VT; Fuster V
    J Lab Clin Med; 1987 Nov; 110(5):634-47. PubMed ID: 3312444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.